Study protocol for a randomised controlled trial of insulin delivery by continuous subcutaneous infusion compared to multiple daily injections

BACKGROUND: Intensive insulin therapy with continuous subcutaneous insulin infusion (CSII) devices or multiple daily injections (MDI) reduces the risk of long-term vascular complications of type I diabetes (TID). Both treatments are used routinely, but there is little evidence to demonstrate superio...

Descripción completa

Detalles Bibliográficos
Autores principales: Blair, Jo, Gregory, John W, Hughes, Dyfrig, Ridyard, Colin H, Gamble, Carrol, McKay, Andrew, Didi, Mohammed, Thornborough, Keith, Bedson, Emma, Awoyale, Lola, Cwiklinski, Emma, Peak, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410001/
https://www.ncbi.nlm.nih.gov/pubmed/25873144
http://dx.doi.org/10.1186/s13063-015-0658-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410001/
https://www.ncbi.nlm.nih.gov/pubmed/25873144
http://dx.doi.org/10.1186/s13063-015-0658-5

Ejemplares similares